A new study by researchers at Fox Chase Cancer Center focusing on pancreatic cancer has shown that a new scoring system can ...

A clinical trial to reverse age-related vision conditions using stem cell treatment could finally deliver on the promise of a ...

SEED Therapeutics, Inc. (“SEED”), a clinical-stage biotechnology company pioneering rationally designed molecular glue ...

Dr. Georg Winter explores how chemical neomorphs can give proteins new functions by reshaping their cellular interactions, ...

The idea that cells could be reset emerged from decades of research in regenerative medicine. The field traces back to 1962, ...

For the roughly 80 million people worldwide living with glaucoma, daily life often means watching the world slowly close in.

From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...

A Survival God for the Age of Abundance,” Peter H. Diamandis and Steven Kotler explore what it means to be human in a world ...

Creative Biogene is proud to announce the launch of its innovative iPSC RNA reprogramming products, specifically designed to enhance the efficiency and safety of iPSC generation.

Endogenous Retroviruses (ERVs), relics from ancient viral infections, form a significant part of vertebrate genomes, including humans, where they constitute ...

Market · GlobeNewswire Inc. The induced pluripotent stem cell (iPSC) market is experiencing robust growth, with a projected ...

A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...